Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto P Meiss

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cancer Letters|May 29, 2012
Concomitant tumor resistancePaula Chiarella, Juan Bruzzo, Roberto P Meiss, et al.
Journal of Cancer Research and Clinical Oncology|August 12, 2010
Biphasic effect of a primary tumor on the growth of secondary tumor implantsJuan Bruzzo, Paula Chiarella, Roberto P Meiss, et al.
Medicina|July 25, 2003
[Molecular pathogenesis of carcinoma of the esophagus]Alejandra M Giménez, Silvia B Copelli, Alfredo H Speroni, et al.
Breast Cancer Research : BCR|October 11, 2007
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signalingAna Quaglino, Carolina Schere-Levy, Leonardo Romorini, et al.
Journal of Virology|September 15, 2006
Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor linesAlbana Gattelli, María N Zimberlin, Roberto P Meiss, et al.
Medicina|February 1, 2015
Meta-tyrosine. A powerful anti-metastatic factor with undetectable toxic-side effectsDamián Machuca, Paula Chiarella, Daniela Montagna, et al.
Cancer Research|February 9, 2012
Concomitant tumor resistance: the role of tyrosine isomers in the mechanisms of metastases controlRaúl A Ruggiero, Juan Bruzzo, Paula Chiarella, et al.
Scientific Reports|January 26, 2018
An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative propertiesJulia Etulain, Hebe A Mena, Roberto P Meiss, et al.
Cancer Research|August 4, 2004
Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activationAlbana Gattelli, María Cecilia Cirio, Ana Quaglino, et al.
Frontiers in Oncology|February 14, 2018
Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-ImmunostimulationPaula Chiarella, Mónica Vermeulen, Daniela R Montagna, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Letters|May 29, 2012
Concomitant tumor resistancePaula Chiarella, Juan Bruzzo, Roberto P Meiss, et al.
Journal of Cancer Research and Clinical Oncology|August 12, 2010
Biphasic effect of a primary tumor on the growth of secondary tumor implantsJuan Bruzzo, Paula Chiarella, Roberto P Meiss, et al.
Medicina|July 25, 2003
[Molecular pathogenesis of carcinoma of the esophagus]Alejandra M Giménez, Silvia B Copelli, Alfredo H Speroni, et al.
Breast Cancer Research : BCR|October 11, 2007
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signalingAna Quaglino, Carolina Schere-Levy, Leonardo Romorini, et al.
Journal of Virology|September 15, 2006
Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor linesAlbana Gattelli, María N Zimberlin, Roberto P Meiss, et al.
Medicina|February 1, 2015
Meta-tyrosine. A powerful anti-metastatic factor with undetectable toxic-side effectsDamián Machuca, Paula Chiarella, Daniela Montagna, et al.
Cancer Research|February 9, 2012
Concomitant tumor resistance: the role of tyrosine isomers in the mechanisms of metastases controlRaúl A Ruggiero, Juan Bruzzo, Paula Chiarella, et al.
Scientific Reports|January 26, 2018
An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative propertiesJulia Etulain, Hebe A Mena, Roberto P Meiss, et al.
Cancer Research|August 4, 2004
Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activationAlbana Gattelli, María Cecilia Cirio, Ana Quaglino, et al.
Frontiers in Oncology|February 14, 2018
Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-ImmunostimulationPaula Chiarella, Mónica Vermeulen, Daniela R Montagna, et al.
Pageof 2